Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Notes Payables (2016 - 2022)

CV Sciences (CVSI) has disclosed Notes Payables for 9 consecutive years, with $952000.0 as the latest value for Q2 2022.

  • Quarterly Notes Payables fell 68.25% to $952000.0 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $952000.0 through Jun 2022, down 68.25% year-over-year, with the annual reading at $612000.0 for FY2021, N/A changed from the prior year.
  • Notes Payables hit $952000.0 in Q2 2022 for CV Sciences, down from $1.0 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $3.0 million in Q2 2021 to a low of $66883.0 in Q1 2018.
  • Historically, Notes Payables has averaged $965245.5 across 5 years, with a median of $612000.0 in 2021.
  • Biggest five-year swings in Notes Payables: surged 4663.52% in 2018 and later plummeted 92.04% in 2019.
  • Year by year, Notes Payables stood at $474000.0 in 2018, then crashed by 85.44% to $69000.0 in 2019, then soared by 426.09% to $363000.0 in 2020, then soared by 68.6% to $612000.0 in 2021, then surged by 55.56% to $952000.0 in 2022.
  • Business Quant data shows Notes Payables for CVSI at $952000.0 in Q2 2022, $1.0 million in Q1 2022, and $612000.0 in Q4 2021.